BR9916432A - Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma - Google Patents

Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma

Info

Publication number
BR9916432A
BR9916432A BR9916432-9A BR9916432A BR9916432A BR 9916432 A BR9916432 A BR 9916432A BR 9916432 A BR9916432 A BR 9916432A BR 9916432 A BR9916432 A BR 9916432A
Authority
BR
Brazil
Prior art keywords
neospora
toxoplasma
treatment
diseases due
triazinone compounds
Prior art date
Application number
BR9916432-9A
Other languages
English (en)
Inventor
Thomas J Kennedy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9916432A publication Critical patent/BR9916432A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"COMPOSTOS DE TRIAZINONA PARA O TRATAMENTO DE DOENçAS DEVIDO AO SARCOCYSTIS, NEOSPORA E AO TOXOPLASMA"<D>. São revelados neste trabalho métodos para tratar terapeuticamente ou metafilaticamente animais infectados suscetíveis ou que sofrem de doenças parasíticas neurológicas ou abortivas devido a um Sarcocystis, Neospora ou Toxoplasma que pode ser tratado com compostos de triazinona através da administração ao mesmo de uma quantidade efetiva farmaceuticamente do composto, incluindo um tratamento terapêutico de dose elevada única.
BR9916432-9A 1998-12-22 1999-12-18 Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma BR9916432A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/218,713 US6194408B1 (en) 1998-12-22 1998-12-22 Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma
PCT/US1999/030293 WO2000037064A2 (en) 1998-12-22 1999-12-18 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Publications (1)

Publication Number Publication Date
BR9916432A true BR9916432A (pt) 2001-09-04

Family

ID=22816196

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916432-9A BR9916432A (pt) 1998-12-22 1999-12-18 Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma

Country Status (17)

Country Link
US (1) US6194408B1 (pt)
EP (1) EP1140102B1 (pt)
JP (1) JP4806121B2 (pt)
KR (1) KR100661102B1 (pt)
CN (1) CN1188128C (pt)
AT (1) ATE270891T1 (pt)
AU (1) AU770108B2 (pt)
BR (1) BR9916432A (pt)
CA (1) CA2356151C (pt)
DE (1) DE69918716T2 (pt)
ES (1) ES2226492T3 (pt)
HK (1) HK1043315A1 (pt)
HU (1) HU228994B1 (pt)
NZ (1) NZ512478A (pt)
PT (1) PT1140102E (pt)
WO (1) WO2000037064A2 (pt)
ZA (1) ZA200104205B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469987B1 (en) 1998-01-13 2002-10-22 Enterasys Networks, Inc. Virtual local area network with trunk stations
CN1189175C (zh) 1998-10-08 2005-02-16 高新研究公司 用于预防和治疗原虫病的组合物和方法
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
EP1276499A2 (en) * 2000-04-25 2003-01-22 Wyeth Equine protozoal myeloencephalitis vaccine
DE10040110A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
US6562007B1 (en) * 2000-09-28 2003-05-13 Bayer Healthcare Llc Adjustable dosage syringe
ATE376422T1 (de) * 2003-01-16 2007-11-15 Janssen Pharmaceutica Nv Diclazurilhaltige antiprotozoenmittel
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
KR101148098B1 (ko) * 2010-04-30 2012-05-22 한국화학연구원 1-［4-（4-니트로-페녹시）-페닐］-프로판-1-온을 유효성분으로 함유하는 톡소포자충 및 콕시디움에 기인한 질환의 예방 및 치료용 조성물
KR101242535B1 (ko) * 2010-10-05 2013-03-12 주식회사이-글벳 콕시듐 치료 및 예방을 위한 조성물의 제조방법
CN102772363B (zh) * 2012-08-22 2013-10-09 青岛康地恩药业股份有限公司 一种含泊那珠利的溶液剂及其制备方法
KR102419769B1 (ko) 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
US20200138823A1 (en) * 2018-11-02 2020-05-07 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2313721A1 (de) * 1973-03-20 1974-10-03 Bayer Ag Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel
AU616916B2 (en) 1987-11-20 1991-11-14 Kissei Pharmaceutical Co. Ltd. 4h-quinolizin-4-one compounds exhibiting therapeutic activities
DE3826058A1 (de) 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US5196562A (en) 1988-10-08 1993-03-23 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US4933341A (en) * 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
EP0377903A3 (de) 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
CA2285477C (en) * 1997-03-31 2006-10-10 The University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
US5830893A (en) * 1997-04-23 1998-11-03 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoan myeloencephalitis using triazinediones

Also Published As

Publication number Publication date
HUP0104710A2 (hu) 2002-04-29
CN1188128C (zh) 2005-02-09
KR20010087412A (ko) 2001-09-15
DE69918716T2 (de) 2005-08-04
HU228994B1 (en) 2013-07-29
CN1331594A (zh) 2002-01-16
NZ512478A (en) 2003-07-25
WO2000037064A3 (en) 2000-10-26
HK1043315A1 (en) 2002-09-13
EP1140102A2 (en) 2001-10-10
HUP0104710A3 (en) 2003-10-28
WO2000037064A2 (en) 2000-06-29
CA2356151A1 (en) 2000-06-29
ATE270891T1 (de) 2004-07-15
AU770108B2 (en) 2004-02-12
US6194408B1 (en) 2001-02-27
AU2370900A (en) 2000-07-12
KR100661102B1 (ko) 2006-12-26
ES2226492T3 (es) 2005-03-16
DE69918716D1 (de) 2004-08-19
PT1140102E (pt) 2004-10-29
CA2356151C (en) 2009-02-24
JP4806121B2 (ja) 2011-11-02
ZA200104205B (en) 2002-05-22
EP1140102B1 (en) 2004-07-14
JP2002532545A (ja) 2002-10-02

Similar Documents

Publication Publication Date Title
BR9916432A (pt) Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
AP2004003069A0 (en) 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
NO20011454L (no) Fremgangsmåter ved administrering av antibiotika
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE447952T1 (de) Synergistische kombination von pumafentrine und salmeterol
BR0010669A (pt) Método para o tratamento de fibrose usando um antagonista da subunidade alfa-4 da integrina
DE69637178D1 (de) N-chlorphenylcarbamate enthaltendes arzneimittel sowie n-chlorphenylthiocarbamate zur hemmung des wachstums von viren
WO2001068125A3 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
BR9910032A (pt) Tienopirimidinas
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
BR9916417A (pt) Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
BR9916391A (pt) Compostos de triazineona para o tratamento de doenças causadas por sarcosiste, neopora e toxoplasma
ATE344664T1 (de) Verbesserte methode zur eradikation von helicobacter pylori
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
SE9803623D0 (sv) New therapeutic application
BR9810930A (pt) Composições farmacêuticas de arglabina e derivados de arglabina
ATE245151T1 (de) Diphenyl-1,2,3-thiadiazol-3-oxide, zusammensetzungen und verfahren zur anwendung
UA49889C2 (uk) Антибактеріальний препарат &#34;бороцин&#34;
BR0002260A (pt) Métodos e composições para o tratamento de distúrbios relacionados com a idade, em animais de companhia

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O C/C ART. 13 DA LPI ) E TAMBEM SE ENCONTRA EM DESACORDO COM OS ARTIGOS 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.